COMP <GO>

MAIA vs TENX // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

MAIA Biotechnology Inc. (NYSE) VS. Tenax Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: MAIA 2 — TENX 1

■ METRIC PARITY

LAST: $1.08 (-1.82%) • MKT CAP: $67.9M

options-implied-move

—

LAST: $1.84 (+2.22%) • MKT CAP: $67.4M

options-implied-move

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MAIA VS. TENX) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	MAIA	TENX	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	—	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-35.00%	0.00	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	—	—	TIE	/fcf-yield <GO>
Operating Margin	—	—	—	TIE	/operating-margins <GO>
Net Profit Margin	—	—	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	—	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	0.23	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	3/9	2/9	+1.00	MAIA	/piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	42.2	45.2	-3.00	TENX	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$67.9M	$67.4M	$553.1K	MAIA	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	MAIA REV	TENX REV	MAIA GROSS %	TENX GROSS %	MAIA FCF	TENX FCF
FY 2025	$68.0M	$157.9M	—	—	-$18.8M	-$35.8M
FY 2024	$47.5M	$54.6M	—	—	-$15.7M	-$14.8M
FY 2023	—	$23.1M	—	—	—	-$5.9M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

MAIA // BETA —

TENX // BETA —